Baltimore-Washington Financial Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-61,634
Closed -$3.81M 96
2015
Q4
$3.81M Sell
61,634
-19,521
-24% -$1.23M 1.19% 40
2015
Q3
$5.12M Sell
81,155
-271
-0.3% -$19.3K 1.63% 21
2015
Q2
$5.95M Buy
81,426
+548
+0.7% +$39.6K 1.77% 15
2015
Q1
$5.29M Buy
80,878
+375
+0.5% +$24.9K 1.54% 31
2014
Q4
$5.24M Buy
80,503
+2,365
+3% +$152K 1.56% 29
2014
Q3
$4.7M Buy
78,138
+5,250
+7% +$343K 1.51% 30
2014
Q2
$5.05M Buy
72,888
+4,245
+6% +$275K 1.57% 26
2014
Q1
$4.49M Buy
68,643
+5,921
+9% +$385K 1.53% 28
2013
Q4
$3.89M Buy
62,722
+620
+1% +$35.9K 1.31% 31
2013
Q3
$3.33M Buy
62,102
+910
+1% +$46.9K 1.32% 36
2013
Q2
$2.79M Buy
+61,192
New +$2.65M 1.21% 41

Other funds holding STJ

Baltimore-Washington Financial Advisors's STJ Position: Q1 2016 in Review

Baltimore-Washington Financial Advisors sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 61,634 shares — an estimated $3.81M sold.

Baltimore-Washington Financial Advisors first reported a position in STJ in Q2 2013 and held it in 11 quarters. The position peaked at $5.95M in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Baltimore-Washington Financial Advisors reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 61,634 St Jude Medical shares in Q1 2016, an estimated $3.81M.
  • Baltimore-Washington Financial Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 11 quarters.
  • Baltimore-Washington Financial Advisors's St Jude Medical position peaked at $5.95M in Q2 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q1 2016, filed 2 May 2016.